Objective: Menarche and menopause mark the lower and upper limits of the female reproductive period. The timing of these events influences women's health in later life. The onsets of menarche and menopause have a strong genetic basis. We tested two genes, TNFRSF11A (RANK) and TNFSF11 (RANKL), for their association with age at menarche (AM) and age at natural menopause (ANM).
T he reproductive period of a woman's life is limited by two key physiological events, menarche and menopause. Although these events per se are experienced by virtually all women, their timing is quite variable. The onset of menarche and menopause was implicated in many consequences for women's health in later life. Early age at menarche (AM) was shown to increase the risk for various cancers, including ovarian, 1,2 endometrial, 3 and breast 4, 5 ; to promote obesity 6, 7 ; and to cause psychological discomfort. 8 Women with later menarche are at higher risk of getting osteoporosis 9,10 and preeclampsia. 11 In turn, age at natural menopause (ANM) is also associated with many postmenopausal health complications, such as osteoporosis, 12, 13 cardiovascular disease, 14 dementia, 15 and various cancers of reproductive organs. 16<19 Postmenopausal health problems are thought to be related to the overall exposure of a female organism to estrogen, that is, the duration of the reproductive period. Therefore, knowing the factors underlying AM and ANM may help to forecast potential health problems and to improve the overall well-being of women.
Because both AM and ANM are complex traits, multiple environmental and genetic factors contribute to them. 20<22 A genetic component of AM variance is estimated to be about 45% to 74%, 23<25 whereas that of ANM ranges between 63% and 74%. 23, 26 During the last few years, several genomic regions and candidate genes that may potentially contribute to AM and ANM have been determined. 27<33 However, this list is probably incomplete.
Tumor necrosis factor receptor superfamily, member 11a (TNFRSF11A), also known as receptor activator of nuclear factor-JB (NF-JB; RANK), and its ligand (TNFSF11 or RANKL) participate in a wide variety of processes controlling cell death and proliferation, immunity, and development of the lymphoid tissue. 34, 35 The TNFRSF11A/TNFSF11 system is widely acknowledged as one of the key players in some primary postmenopausal disorders, such as osteoporosis 36, 37 and atherosclerosis. 38 In addition, these genes are expressed in mammalian gland cells and were shown to control the development of a lactating mammary gland during pregnancy 39 ; that is, they play a role in the reproductive system. Collectively, the above data suggest that TNFRSF11A and TNFSF11 may contribute to AM and ANM.
METHODS

Study participants
The study participants were recruited from the metropolitan area of Omaha, NE, as described previously. 40 The study protocol was approved by the institutional review board of Creighton University. Each participant signed an informed consent agreement before enrollment in the project. To minimize an effect of potential nongenetic confounding factors, the following exclusion criteria, which were developed previously, 41 were applied to the recruitment: chronic diseases of vital organs (brain, lung, heart, liver, and kidney), systemic metabolic diseases (including diabetes, hypoparathyroidism and hyperparathyroidism, hyperthyroidism, etc), malnutrition conditions (chronic diarrhea, chronic ulcerative colitis, etc), and ANM below 40 years (as an indicator of probable premature ovarian failure). A participant's compliance to the exclusion criteria was evaluated through nurse-administered questionnaires and/or medical records. The recruited women provided the following information about their reproductive history and lifestyle factors: use of hormonal contraceptives, parity, duration of breast-feeding, smoking habits, and use of alcohol. The total study sample consisted of 306 otherwise healthy white women of European descent. For the population association and haplotype analysis of AM and ANM, the total sample was partitioned into two subsamples of 306 and 211 participants, respectively. Women with surgical menopause were excluded from the analysis of ANM.
AM was defined as the age at the first menstrual period minus the date of birth; ANM was calculated as the age at the last menstrual period (y) followed by 1 year without menses. The summary of the data about the participants are given in Table 1 .
Genotyping
Genomic DNA was isolated from the leukocytes of peripheral blood using a commercially supplied kit (Gentra Systems, Inc., Minneapolis, MN) and according to the manufacturer's protocol. SNP genotyping was performed off-site using an Integrated BeadArray System (Illumina, Inc.). In total, 19 SNPs located within and near TNFRSF11A and 12 SNPs for TNFSF11 were genotyped.
Statistical analyses
The concordance of the SNPs to the Hardy-Weinberg equilibrium was checked using the W 2 test. The consistency of genotype data with Mendelian inheritance was verified using PedCheck. 42 Some SNPs had only a few minor allele homozygotes in the sample. To increase the power of the analysis, those homozygotes were pooled with heterozygotes, and thus, two groups (with or without the minor allele) instead of three (minor allele homozygote, heterozygote, and major allele homozygote) were analyzed. The participants of the ANM subsample were divided into categories according to the number of pregnancies and months of breast-feeding ( Table 1) .
The effects of the studied SNPs and environmental factors and their interactions on AM and ANM were estimated by stepwise multiple regression analysis and univariate analysis of variance. In the latter case, each SNP was analyzed independently. Haplotype blocks were initially determined using the procedure implemented in Haploview 43 and then analyzed for their association with the traits under study. Because the current population sample came from our previous studies, which showed the significant effect of smoking, alcohol consumption, and duration of breast-feeding on ANM, 28, 44 these variables were used as covariates in the subsequent association analysis of ANM. No lifestyle factors were used as covariates for the AM association analyses, as they all occurred presumably after menarche. The analyses were conducted 
RESULTS
Study participants' characteristics
In total, 306 women were recruited for the study. Their mean T SE AM was 13.0 T 0.1 years, and the mean T SE ANM was 45.7 T 0.4 years. The ANM of the total sample was relatively low because of the inclusion of participants who had experienced surgical menopause (hysterectomy or oophorectomy). The mean age at surgical menopause for this sample is about 40 years. 46 The ANM in the respective subsample was higher (48.9 T 0.3 y; Table 1 ) but still lower than the average ANM for the US female population (about 51 y). This difference may be attributed to the interpopulation variation in ANM across the country.
SNP association analyses
All studied SNPs were in agreement with the Hardy-Weinberg equilibrium ( Table 2 ). Three TNFSF11 polymorphisms showed an association with AM: rs2200287 (P = 0.005), rs9525641 (P = 0.039), and rs1054016 (P = 0.047; Table 3 ). After correction for multiple testing, only rs2200287 showed a nearly significant (P = 0.063) association. Two SNPs of this gene, rs346578 and rs9525641, were significantly associated with ANM (P = 0.007 and P = 0.011, respectively). After correction for multiple testing, the rs346578 association became nearly significant (P = 0.080) and another became nonsignificant (P = 0.130). On the other hand, when being analyzed without the covariates, the association of rs346578 remained significant (P = 0.032) even after the multiple testing correction.
One SNP of TNFRSF11A, rs3826620, was significantly associated with AM (P = 0.022), and another, rs8086340, was associated with ANM (P = 0.015). Neither association remained significant after correction for multiple testing. The effects of the TNFRSF11A and TNFSF11 polymorphisms on the respective traits are modest (Table 3) . For example, homozygotes at the minor allele of rs3826620 have about 0.7 year later menarche (13.7 T 0.3 y) than the average for the sample (13.0 T 0.1 y). Likewise, a minor allele of rs8086340 confers about 1 year later menopause (50.8 T 0.6 y) than the mean ANM for the studied sample (48.9 T 0.3 y).
Several haplotypes of both genes were found to be associated with the studied traits. Specifically, the AT haplotype of polymorphisms rs3826620 and rs12969194 of the TNFRSF11A gene was significantly associated with AM (P = 0.022), and the TA haplotype of the same polymorphisms 49.9 T 0.7 (36.5) 0.011/0.020 SNP, single nucleotide polymorphism; TNFRSF11A, tumor necrosis factor receptor superfamily, member 11a; TNFSF11, tumor necrosis factor (ligand) superfamily, member 11; AM, age at menarche; ANM, age at natural menopause. a 11, 12, and 22 denote homozygote at minor allele, heterozygote, and homozygote at major allele, respectively (the missed values for homozygotes at minor allele indicate that they were combined with heterozygotes into a single group); numbers in parentheses indicate percentage of the studied sample. Adjusted for covariates/crude. was significantly associated with ANM (P = 0.046). Two identified haplotype blocks of TNFSF11 are associated with the studied traits (Table 4 ). Interestingly, the haplotypes, which are associated with both AM and ANM, have an opposite effect on the traits. For example, the ATTG haplotype confers earlier AM but later ANM, and so does the AATAAG haplotype (Table 4 ). Overall, the effect of the haplotypes is modest: each of them explains, on average, about 2% of the trait variance.
Several significant interaction effects between the TNFRSF11A and TNFSF11 polymorphisms on the studied traits were also detected ( Table 5 ). The rs4436867 polymorphism of TNFRSF11A interacts with the four TNFSF11 polymorphisms in their effect on ANM. Two TNFRSF11A polymorphisms, rs4941125 and rs7235803, manifest an interaction effect with several TNFSF11 polymorphisms on AM. Interestingly, none of the listed SNPs manifests the interaction effect on both AM and ANM (Table 5 ).
Both studied genes seem to interact with various lifestyle factors in their effect on ANM. In terms of the number of the interactions, duration of breast-feeding has the strongest effect on ANM: all TNFSF11 polymorphisms and 17 of the 19 studied TNFRSF11A SNPs indicated a significant (P G 0.05) interaction with this factor. The rs8086340 polymorphism of TNFRSF11A interacts with smoking (P = 0.028), and the rs9525641 polymorphism of TNFSF11 was shown to interact with alcohol consumption (P = 0.037). In addition, many polymorphisms of both genes showed nearly significant (P e 0.07) interactions with these two factors (data not shown).
DISCUSSION
TNFRSF11A and TNFSF11 are two functionally linked genes and are therefore frequently considered together as to their role in the determination of various traits. However, virtually no data exist about their probable contribution to menarche and/or menopause. Some speculations may be made based on the known function of these genes. At the molecular level, their primary function is the activation of the transcription factor NF-JB. 47 In turn, the transcription factor NF-JB signaling pathway controls the expression of a wide variety of genes involved in cell proliferation and survival. 48 Therefore, TNFRSF11A and TNFSF11 are pleiotropic genes and were thus implicated for various complex processes, for example, bone remodeling, vascular diseases, and immunity. 34, 35, 37, 38 Furthermore, there is evidence that the transcription factor NF-JB signaling pathway is associated with cell aging and age-related diseases. 49<52 Recent data from the integrated microarray study of nine tissues reinforced the role of this pathway in senescence. 53 It seems probable that TNFRSF11A and TNFSF11 contribute to AM and ANM by activating the transcription factor NF-JB signaling pathway and, respectively, triggering the mechanisms of aging. The effect of these genes on timing of menarche and menopause is probably estrogen dependent. For example, there is ample evidence about estrogen modulation of TNFRSF11A and TNFSF11 expression in osteogenic cell lineages that was implicated in postmenopausal bone loss due to the cessation of the ovarian function and, respectively, estrogen depletion. 54<57 Although no data about the estrogen effect on TNFRSF11A and TNFSF11 during puberty are available, we can assume the opposite mechanism owing to the activation of the ovaries. This possibility should not be rejected, as the contribution of estrogen and estrogen-metabolizing genes to AM is evidenced by several studies. 29 ,58<61 However, the details of the estrogen effect on TNFRSF11A and TNFSF11 during menarche are yet to be determined.
Despite the fact that most of the single SNP associations determined in this study became nonsignificant after correction for multiple testing, they should not be rejected. The Bonferroni correction is conservative and tends to reject the null hypothesis and mask a real association, especially when the effect of the given SNP is weak, which is common for pleiotropic genes, like those in the present study.
In addition to estrogen, other hormones control the expression of TNFRSF11A and TNFSF11. 62<65 Given that the hormonal status during menarche and menopause changes drastically, 66<68 this may suggest respective alterations in the genes' activity. There are also data about the prolactincontrolled role of TNFRSF11A and TNFSF11 in mammary gland development during pregnancy. 69, 70 The strong interactions between these genes and the duration of lactation reported here are in good agreement with these data.
The observed interactions between TNFSF11 and smoking and alcohol consumption are supported by available literature data, which documented the stimulating effect of these factors on the TNFSF11 expression. 71<76 We have not found any experimental evidence about the effect of these factors on TNFRSF11A, and, therefore, it is difficult to hypothesize the mechanism of this effect. One of the possible ways may be that they may influence TNFRSF11A through TNFSF11. However, the observed significant interactions should be treated with certain caution, as sample size is small and, respectively, statistical power to detect interactions is limited.
Another possible problem is recall bias, which may be introduced when obtaining the data through a questionnaire. According to the previous studies, the accuracy of long-term recall of AM and self-reported ANM varied between 70% and 84%. 77<80 The question about the shared genetic basis of AM and ANM is still disputed. These traits were reported as either phenotypically correlating 81, 82 or not. 23, 83 However, recent genetic studies provide more and more evidence that some genes 27, 60, 84 and genomic regions 30, 32 may contribute to both AM and ANM. Similar to our previous study of the methylenetetrahydrofolate reductase gene, 44 the present work gives further support to the shared genetic basis for AM and ANM.
Despite the fairly good knowledge of the NF-JB signaling pathway per se, 85 a probable contribution of its components (including TNFRSF11A and TNFSF11) to AM and ANM remains largely elusive. This study provides evidence for a possible role of this pathway in the timing of menarche and menopause.
CONCLUSIONS
This study first reports TNFRSF11A and TNFSF11, two important genes for various complex traits, as probable contributors to the onset of menarche and natural menopause. This contribution incorporates direct associations and SNP-SNP and SNP-environment interactions. However, the currently available data on these genes are limited and do not allow for making any definite conclusions about an exact mechanism of their effect on AM and ANM. More studies, including functional ones, on other cohorts of women are needed to determine this mechanism and verify the results of the present study.
